Utility of Mycobacterium tuberculosis PCR in ruling out active disease and impact on isolation requirements in a low prevalence setting
Ahmed Hamdi(Mayo Clinic in Florida), Nancy L. Wengenack(Mayo Clinic), Madiha Fida(Mayo Clinic), Sharon M. Deml(Mayo Clinic), Omar Abu Saleh(Mayo Clinic in Florida)
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
August 17, 2020
Cited by 13
Related Papers
Retrospective Analysis of Antimicrobial Susceptibility Profiles of <i>Nocardia</i> Species from a Tertiary Hospital and Reference Laboratory, 2011 to 2017
|Antimicrobial Agents and Chemotherapy|2019|101
Diagnostic Value of 16S Ribosomal RNA Gene Polymerase Chain Reaction/Sanger Sequencing in Clinical Practice
|Clinical Infectious Diseases|2021|59
Detection of Pathogenic Bacteria From Septic Patients Using 16S Ribosomal RNA Gene–Targeted Metagenomic Sequencing
|Clinical Infectious Diseases|2021|58
Rapid multiplex PCR panel for pneumonia in hospitalised patients with suspected pneumonia in the USA: a single-centre, open-label, pragmatic, randomised controlled trial
|The Lancet Microbe|2024|50
Management and treatment of Aerococcus bacteremia and endocarditis
|International Journal of Infectious Diseases|2020|44